Physician

Jill Scott Vargo, M.D.

According to 2025 Medicare claims, Jill Vargo, M.D. (NPI: 1205899143) practices rheumatology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (NPI: 1780647578; TIN: 56-1426545) and primary practice location at 28803-1700. Vargo is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Vargo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 595 traditional Medicare patients, billed 197,239 HCPCS/CPT codes, and received $2,045,233 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,113 prescription claims across 445 beneficiaries totaling $2,307,232 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 11 claims. Open Payments data shows 105 records totaling $33,555. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	933	132,646	$2,308,990
2016	916	154,377	$2,540,852
2017	725	111,634	$1,916,420
2018	722	141,433	$2,693,974
2019	683	144,870	$2,645,733
2020	646	153,490	$2,420,255
2021	665	159,184	$2,368,046
2022	597	138,185	$1,932,781
2023	612	165,318	$1,916,418
2024	595	197,239	$2,045,233

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	639	7,520	$1,710,643
2016	638	7,304	$1,655,438
2017	578	6,446	$1,771,887
2018	565	5,935	$1,817,839
2019	534	5,747	$1,661,425
2020	511	5,341	$1,653,370
2021	482	4,785	$1,779,196
2022	450	4,332	$1,831,813
2023	439	4,221	$2,010,027
2024	445	4,113	$2,307,232

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$359
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	322	477	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	341	447	$13
36415	Insertion of needle into vein for collection of blood sample	324	627	$9
82565	Blood creatinine level	397	855	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	258	660	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	63	1,772	$615,232
Rinvoq	Upadacitinib	69	2,070	$440,569
Enbrel Sureclick	Etanercept	41	1,148	$303,599
Enbrel	Etanercept	23	656	$166,874
Benlysta	Belimumab	26	728	$136,132

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$33,555	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jill Scott Vargo, M.D.?

Tedicare shows public-source Medicare data for Jill Scott Vargo, M.D. (NPI 1205899143), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jill Scott Vargo, M.D. have ACO affiliation data?

Jill Scott Vargo, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Jill Scott Vargo, M.D.?

Jill Scott Vargo, M.D. is linked to ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (billing NPI 1780647578) in the available physician profile data.

Does Jill Scott Vargo, M.D. have Open Payments data?

Jill Scott Vargo, M.D. has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.